Pharmacologic shifting of a balance between protein refolding and degradation mediated by Hsp90Christine Schneider, F. Ulrich Hartl, Laura Sepp‐Lorenzino et al.|Proceedings of the National Academy of Sciences|1996Cited by 409
AFQ056 treatment of levodopa‐induced dyskinesias: Results of 2 randomized controlled trialsDaniela Berg, Baltazar Gomez‐Mancilla, María Stamelou et al.|Movement Disorders|2011Cited by 173
Subtypes of mild cognitive impairment in patients with Parkinson's disease: evidence from the LANDSCAPE studyElke Kalbe, Richard Dodel, Sarah Rehberg et al.|Journal of Neurology Neurosurgery & Psychiatry|2016Cited by 102
Cognitive decline in Parkinson’s disease: the impact of the motor phenotype on cognitionJennifer Wojtala, Kathrin Reetz, Ines Ann Heber et al.|Journal of Neurology Neurosurgery & Psychiatry|2018Cited by 87